Vidan Diagnostics to attend the 2023 AACC Annual Scientific Meeting and Clinical Lab Expo

Vidan Diagnostics to attend the 2023 AACC Annual Scientific Meeting and Clinical Lab Expo Vidan Diagnostics will be in attendance at the 2023 AACC Annual Scientific Meeting and Clinical Lab Expo in Anaheim, CA in July 2023. Vidan Diagnostics is a supplier of in-vitro diagnostic products. We deliver high quality, easy to use, [...]

Vidan Diagnostics to attend the 2023 AACC Annual Scientific Meeting and Clinical Lab Expo2023-01-12T15:34:47+00:00

Vidan Diagnostics Beta-hydroxybutyrate Assay Prefered by Hospital Laboratories

Vidan Diagnostics Beta-hydroxybutyrate Assay Prefered by Hospital Laboratories Proficiency Testing Programs Indicate Increase in Participants of Beta-Hydroxybutyrate 21 FS Reagent SAN ANTONIO, Texas, November 18, 2022 - Vidan Diagnostics, LLC today announced that its Beta-hydroxybutyrate 21 FS assay is preferred by hospital laboratories as an alternative to other commercially available testing methods on the [...]

Vidan Diagnostics Beta-hydroxybutyrate Assay Prefered by Hospital Laboratories2022-11-29T16:22:38+00:00

Vidan Diagnostics Delivers Record Revenue Performance in 2021

Vidan Diagnostics Key Focus Remains on Implementing Its Strategy To Position Its Beta-Hydroxybutyrate Core Business in 2022 SAN ANTONIO, TEXAS — April 21, 2022 — Vidan Diagnostics, LLC, a U.S based supplier of in-vitro diagnostic products focused in the areas of diabetes, sepsis, heart disease & stroke, and anemia, announces its final results for [...]

Vidan Diagnostics Delivers Record Revenue Performance in 20212022-11-23T17:19:36+00:00

2022 AACC Annual Scientific Meeting and Clinical Lab Expo

Vidan Diagnostics to attend the 2022 AACC Annual Scientific Meeting and Clinical Lab Expo Vidan Diagnostics in partnership with Diasys Diagnostics Systems will be in attendance at the 2022 AACC Annual Scientific Meeting and Clinical Lab Expo in Chicago, IL in July 2022. Both companies will feature products to include the recently launched Next [...]

2022 AACC Annual Scientific Meeting and Clinical Lab Expo2023-01-11T16:24:23+00:00

Beta-Hydroxybutyrate Validation Samples

Vidan Diagnostics Introduces Patient Samples to Validate Beta-Hydroxbutyrate Assay SAN ANTONIO, Texas, October 27, 2021 - Vidan Diagnostics, LLC today announced the availability of it’s beta-hydroxybutyrate validation samples for customers interested in evaluating Vidan Diagnostics’ Next Generation β-Hydroxybutyrate 21FS Reagent. Beta-hydroxybutyrate Validation Patient Samples CLIA (42 CFR 493.1253) and CAP (GEN 42020-42163) require that [...]

Beta-Hydroxybutyrate Validation Samples2022-11-23T17:20:16+00:00

Beta-hydroxybutyrate Assay For Roche Cobas®Pro Integrated Solutions

Vidan Diagnostics Launches Next Generation βeta-Hydroxybutyrate Assay on Roche Cobas® Pro C 503 SAN ANTONIO, Texas, August 16, 2021 - Vidan Diagnostics, LLC today announced that it has validated and released its reagent application for its Next Generaton Beta-hydroxybutyrate 21FS Reagent on the Roche cobas® pro c 503 clinical chemistry system. With cobas® pro [...]

Beta-hydroxybutyrate Assay For Roche Cobas®Pro Integrated Solutions2022-11-23T17:20:33+00:00

Lucidplus™ Beta-hydroxybutyrate Assay Preffered by Hospital Laboratories

Proficiency Testing Programs Indicate Increase in Participants of Lucidplus™ Beta-Hydroxybutyrate Assay SAN ANTONIO, Texas, June 10, 2021 - Vidan Diagnostics, LLC today announced that its Lucidplus™ whole blood beta-hydroxybutyrate assay is preferred by hospital laboratories as an alternative to other commercially available testing methods on the market. Since its launch in June 2018, the [...]

Lucidplus™ Beta-hydroxybutyrate Assay Preffered by Hospital Laboratories2022-11-23T17:20:52+00:00

Next Generation Beta-hydroxybutyrate Reagent For Beckman Coulter AU® Clinical Chemistry Systems

Vidan Diagnostics Extends Reagent Stability for β-Hydroxybutyrate 21FS Assay on Beckman AU® Clinical Chemistry Systems SAN ANTONIO, Texas, April 28, 2021 - Vidan Diagnostics, LLC today announced that it has extended the shelf-life of its Next Generaton Beta-hydroxybutyrate 21FS Reagent to two years from date of manufacture. This assay can be used on any open-channel [...]

Next Generation Beta-hydroxybutyrate Reagent For Beckman Coulter AU® Clinical Chemistry Systems2022-11-23T17:21:28+00:00

Availability of Beta-hydroxybutyrate on Roche cobas® Clinical Chemistry Systems

Reagent Application for β-Hydroxybutyrate 21FS Assay Now Available for Roche cobas® Clinical Chemistry Systems SAN ANTONIO, Texas, October 16, 2020 - Vidan Diagnostics, LLC today announced that it has validated the reagent application for its β-Hydroxybutyrate 21FS Next Generation Reagent to be used on the Roche cobas® clinical chemistry systems. Roche is a market [...]

Availability of Beta-hydroxybutyrate on Roche cobas® Clinical Chemistry Systems2022-11-23T17:23:06+00:00

Availability of of Beta-hydroxybutyrate on Siemens Atellica®

Vidan Diagnostics Launches Reagent Application for its β-Hydroxybutyrate 21FS Assay on the Siemens Atellica® Clinical Chemistry System. SAN ANTONIO, Texas, August 21, 2020 - Vidan Diagnostics, LLC today announced that its β-Hydroxybutyrate 21FS Next Generation Reagent is now available on the Siemens Atellica® clinical chemistry system. Beta-Hydroxybutyrate (BHB) is an important marker when used in [...]

Availability of of Beta-hydroxybutyrate on Siemens Atellica®2022-11-23T17:23:56+00:00
Go to Top